Baird Maintains Neutral on Omada Health, Raises Price Target to $25
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Baird analyst Vikram Kesavabhotla maintains Omada Health (NASDAQ:OMDA) with a Neutral and raises the price target from $15 to $25.
Baird analyst Vikram Kesavabhotla maintains Omada Health (NASDAQ:OMDA) with a Neutral and raises the price target from $15 to $25.